| Literature DB >> 35510205 |
Afef Bahlous1, Asma Krir1, Mehdi Mrad2, Mouna Bouksila2, Safa Kalai1, Osman Kilani1, Kateb Elhem Cheour El3, Hela Sahli2, Nizar Laadhari4.
Abstract
Background: Vitamin D deficiency is one of the most common medical conditions worldwide. In Tunisia, several studies evaluated Vitamin D status, but this was concerning specific populations (pregnant women, obese or diabetic patients and children with asthma). The only study that evaluated Vitamin D status in a healthy Tunisian population was conducted by Meddeb and associeties in 2002. The update of data available, based on the currently recommended limits, is necessary. This study aimed to estimate the prevalence of hypovitaminosis D in a healthy Tunisian population, and correlate the values with potential risk factors.Entities:
Keywords: Tunisia; healthy volunteers; parathyroid hormone; prevalence; vitamin D deficiency
Year: 2022 PMID: 35510205 PMCID: PMC9010047 DOI: 10.5937/jomb0-30247
Source DB: PubMed Journal: J Med Biochem ISSN: 1452-8266 Impact factor: 2.157
Recommended 25-hydroxyvitamin D concentrations according to the research and information group on osteoporosis.
| 25 (OH) D levels | ||
|---|---|---|
| UNIT | ng/mL | nmol/L |
| Hypovitaminosis D | ||
| – Deficiency | < 10 | < 25 |
| – Insufficiency | 10–29 | 25–74 |
| Optimal level | ≥ 30 | ≥ 75 |
Sociodemographic and biochemical characteristics of the sample (N=196).
SD: Standard deviation, BMI: Body mass index, PTH: Parathormone, 25 (OH)D: 25 hydroxyvitamin D
| VARIABLE | VALUE |
|---|---|
| Mean age ± SD (years) | 36.9 ± 6.4 |
| Extreme ages (years) | 22–56 |
| Sex (F/M) | 103/ 93 |
| Female (%) | 52 |
| Habitat (urban/rural) | 174/22 |
| Urban habitat (%) | 88.8 |
| Socioeconomic level<br>– Low (%)<br>– Medium (%)<br>– High (%) | 7.1<br>88.8<br>4.1 |
| Phototype <br>– II<br>– III<br>– IV | 6<br>189<br>1 |
| Solar exposure score ≥ 3 (%) | 10.2% |
| Sunscreen use (%) | 43.4% |
| Veiled women (N=103) (%) | 35% |
| Smoking<br>Average pack-year ± SD | 18.9%<br>7.6 ± 5.2 |
| Average BMI ± SD (kg/m2)<br>– Normal weight (%)<br>– Overweight (%)<br>– Obese (%) | 25.91 ± 3.93<br>45<br>41<br>14 |
| Average systolic blood pressure ± SD (mmHg) | 109.6 ± 11.7 |
| Average diastolic blood pressure ± SD (mmHg) | 69.11 ± 10.45 |
| Vitamin D nutritional intakes<br>– Average intakes ± SD (mg/day)<br>– Insufficient intakes (%) | 2.88 ± 1.73<br>89.3 |
| Calcium nutritional intakes<br>– Average intakes ± SD (mg/day)<br>– Insufficient intakes (%) | 602.12 ± 26991.3 |
| Mean glycemia level ± SD (mmol/L) | 5 ± 0.3 |
| Mean serum creatinine level ± SD (μmol/L) | 61.6 ± 12.9 |
| Mean serum calcium level ± SD (mmol/L) | 2.46 ± 0.07 |
| Mean serum phosphate level ± SD (mmol/L) | 1.06 ± 0.15 |
| Mean serum alkaline phosphatase level ± SD (IU/L) | 67.56 ± 20.3 |
| Mean serum PTH level ± SD (pmol/L) | 4.6 ± 1.7 |
| Mean serum 25 (OH)D level ± SD (nmol/L) | 31.8 ± 25.7 |
Parathyroid hormone concentrations according to vitamin D range.
| Vitamin D (nmol/L) | PTH (pmol/L)<br>mean ± standard deviation |
|---|---|
| < 25 | 4.9 ± 1.9 |
| 25–74 | 4.42 ± 1.38 |
| > 75 | 3.7 ± 1.1 |